1. Home
  2. CRBU vs CPSS Comparison

CRBU vs CPSS Comparison

Compare CRBU & CPSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRBU
  • CPSS
  • Stock Information
  • Founded
  • CRBU 2011
  • CPSS 1991
  • Country
  • CRBU United States
  • CPSS United States
  • Employees
  • CRBU N/A
  • CPSS N/A
  • Industry
  • CRBU Medicinal Chemicals and Botanical Products
  • CPSS Finance: Consumer Services
  • Sector
  • CRBU Health Care
  • CPSS Finance
  • Exchange
  • CRBU Nasdaq
  • CPSS Nasdaq
  • Market Cap
  • CRBU 179.7M
  • CPSS 164.5M
  • IPO Year
  • CRBU 2021
  • CPSS 1992
  • Fundamental
  • Price
  • CRBU $2.32
  • CPSS $8.16
  • Analyst Decision
  • CRBU Strong Buy
  • CPSS
  • Analyst Count
  • CRBU 3
  • CPSS 0
  • Target Price
  • CRBU $6.67
  • CPSS N/A
  • AVG Volume (30 Days)
  • CRBU 1.1M
  • CPSS 26.6K
  • Earning Date
  • CRBU 11-07-2025
  • CPSS 11-06-2025
  • Dividend Yield
  • CRBU N/A
  • CPSS N/A
  • EPS Growth
  • CRBU N/A
  • CPSS N/A
  • EPS
  • CRBU N/A
  • CPSS 0.80
  • Revenue
  • CRBU $9,121,000.00
  • CPSS $192,257,000.00
  • Revenue This Year
  • CRBU $8.06
  • CPSS $143.76
  • Revenue Next Year
  • CRBU N/A
  • CPSS $14.32
  • P/E Ratio
  • CRBU N/A
  • CPSS $9.70
  • Revenue Growth
  • CRBU N/A
  • CPSS 2.04
  • 52 Week Low
  • CRBU $0.66
  • CPSS $6.67
  • 52 Week High
  • CRBU $3.00
  • CPSS $12.73
  • Technical
  • Relative Strength Index (RSI)
  • CRBU 47.97
  • CPSS 47.34
  • Support Level
  • CRBU $2.35
  • CPSS $7.78
  • Resistance Level
  • CRBU $2.59
  • CPSS $8.32
  • Average True Range (ATR)
  • CRBU 0.21
  • CPSS 0.47
  • MACD
  • CRBU -0.06
  • CPSS 0.01
  • Stochastic Oscillator
  • CRBU 11.43
  • CPSS 38.14

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

About CPSS Consumer Portfolio Services Inc.

Consumer Portfolio Services Inc is a U.S based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.

Share on Social Networks: